These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8639861)

  • 1. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
    Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
    Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.
    Loyevsky M; Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
    J Clin Invest; 1993 Jan; 91(1):218-24. PubMed ID: 8423220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
    Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
    J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis.
    Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
    Blood; 1994 Aug; 84(3):910-5. PubMed ID: 8043872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation.
    Darnell G; Richardson DR
    Blood; 1999 Jul; 94(2):781-92. PubMed ID: 10397746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron chelators: mode of action as antimalarials.
    Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
    Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal.
    Lytton SD; Cabantchik ZI; Libman J; Shanzer A
    Mol Pharmacol; 1991 Oct; 40(4):584-90. PubMed ID: 1921988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.
    Lytton SD; Mester B; Dayan I; Glickstein H; Libman J; Shanzer A; Cabantchik ZI
    Blood; 1993 Jan; 81(1):214-21. PubMed ID: 8417790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Determinants of antimalarial activity of reversed siderophores.
    Tsafack A; Libman J; Shanzer A; Cabantchik ZI
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2160-6. PubMed ID: 8878599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D; Ponka P; Baker E
    Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP; Porter JB
    Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of antimalarial effect of ICL670A on in vitro cultures of Plasmodium falciparum.
    Goudeau C; Loyevsky M; Kassim OO; Gordeuk VR; Nick H
    Br J Haematol; 2001 Dec; 115(4):918-23. PubMed ID: 11843826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of iron chelators on proliferation and iron uptake in hepatoma cells.
    Kicic A; Chua AC; Baker E
    Cancer; 2001 Dec; 92(12):3093-110. PubMed ID: 11753989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.
    Loyevsky M; John C; Dickens B; Hu V; Miller JH; Gordeuk VR
    Mol Biochem Parasitol; 1999 Jun; 101(1-2):43-59. PubMed ID: 10413042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR; Tran EH; Ponka P
    Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
    Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
    Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.